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Abstract
Background: A small proportion of the population consumes the majority of health care resources. High-cost
health care users are a heterogeneous group. We aim to segment a provincial population into relevant
homogenous sub-groups to provide actionable information on risk factors associated with high-cost health care
use within sub-populations.
Methods: The Canadian Institute for Health Information (CIHI) Population Grouping methodology was used to
define mutually exclusive and clinically relevant health profile sub-groups. High-cost users (> = 90th percentile of
health care spending) were defined within each sub-group. Univariate analyses explored demographic, socio-
economic status, health status and health care utilization variables associated with high-cost use. Multivariable
logistic regression models were constructed for the costliest health profile groups.
Results: From 2015 to 2017, 1,175,147 individuals were identified for study. High-cost users consumed 41% of total
health care resources. Average annual health care spending for individuals not high-cost were $642; high-cost users
were $16,316. The costliest health profile groups were ‘long-term care’, ‘palliative’, ‘major acute’, ‘major chronic’,
‘major cancer’, ‘major newborn’, ‘major mental health’ and ‘moderate chronic’. Both ‘major acute’ and ‘major cancer’
health profile groups were largely explained by measures of health care utilization and multi-morbidity. In the
remaining costliest health profile groups modelled, ‘major chronic’, ‘moderate chronic’, ‘major newborn’ and ‘other
mental health’, a measure of socio-economic status, low neighbourhood income, was statistically significantly
associated with high-cost use.
Interpretation: Model results point to specific, actionable information within clinically meaningful subgroups to
reduce high-cost health care use. Health equity, specifically low socio-economic status, was statistically significantly
associated with high-cost use in the majority of health profile sub-groups. Population segmentation methods, and
more specifically, the CIHI Population Grouping Methodology, provide specificity to high-cost health care use;
informing interventions aimed at reducing health care costs and improving population health.
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Introduction
Increasing health care costs are challenging health care
systems in Canada and around the world. Health care
expenditure in nearly every developed country meets or
exceeds 10% of gross domestic product [31]. Evidence
has long demonstrated that a small proportion of the
population (< 10%) accounts for the majority (50–70%)
of total health care spending [7, 20, 21, 26]; individuals
commonly referred to as ‘high-cost users’.
High-cost users are a heterogeneous population. From
1985 (n = 79) to 2018 (n = 1198) the number of PubMed
citations involving the term ‘high-cost use’ has increased
over 15 times [17]. In general, previous studies have
found high-cost health care use to be associated with: 1)
complex, multiple chronic conditions (multi-morbidity),
2) catastrophic illness (for example, motor vehicle acci-
dent or major cancer), 3) high costs at end-of-life, 4)
mental health and addictions, 5) institutional living, and,
6) various indicators of lower socio-economic status (for
example, food insecurity and poverty) – including com-
binations thereof. A recent systematic review on high-
cost health care users identified similar patterns: multi-
morbidity, mental health and addictions, increasing age,
end-of-life care and socio-economic status were the pre-
dominant factors associated with high-cost use across 55
countries globally [29].
One of the pioneers in understanding high-cost health
care use is Dr. Jeffrey Brenner and his team in Camden,
New Jersey. They found high-cost users were predomin-
ately located in two high-rise urban apartment buildings
in an impoverished neighbourhood in Camden City.
Case management strategies, such as providing ‘wrap-
around’ care for complex patients, aimed specifically at
the identified population both improved health out-
comes and reduced cost [6, 12].
When public health action is focused on a relatively
small population, such as the one in Camden, New
Jersey [6, 12] it is easier for the insurers to describe
and create policies aimed at improving health out-
comes and reducing inappropriate health care costs.
For example, an interdisciplinary team of care pro-
viders in Camden were able to co-ordinate their
services within a specific geographical location and a
relatively homogenous population (low socio-economic
status). However, when a population is more diffuse
and broad, as is the case with publicly insured pro-
vincial populations in Canada, describing and creating
policies aimed at reducing high-cost health care use
are more difficult.
High-cost user studies can overlook health equity con-
siderations, even when segmenting the population into
meaningful sub-groups based on disease profiles [11,
16]. To that end, we aimed to understand, by specific
mutually exclusive health profile groups, factors driving
high-cost health care use within each health profile
group under study. By defining ‘high-cost use’ within
sub-groups, we achieve better specificity to the high-
cost definition. For example, if one were to define
‘high-cost use’ as those in the > = 90th percentile of
spending in the provincial population overall, factors
that are related to high-cost use in general would be
understood; however, nuances of factors that may be
associated with high-cost use within a specific subset,
such as acute disease versus chronic disease, would
be lost.
Study objectives
1) To describe and define high-cost health care use in
the provincial population of Saskatchewan, Canada and,
2) From the perspective of a provincial government
funding health care in Canada, to explore risk factors as-
sociated with high-cost health care use within specific
health profile groups.
In the current study, ‘actionable’ is defined as quantita-
tively understanding risk factors associated with high-
cost use, within sub-populations, including variables that
are typically included in modelling high-cost use but less
amenable to change (for example, age) with variables
that may be more amenable to change and therefore ‘ac-
tionable’ through targeted programmatic or policy inter-
ventions (for example, socio-economic status).
Achieving equity in health is one of the key drivers of
this research; high-cost health care users are more costly
to the health care system, but, why is not necessarily
clear. Previous research has demonstrated that disease
burden is higher amongst the poor and poverty leads to
poor health outcomes. Health care systems need to con-
sider and address the underlying social determinants of
health of the populations they serve. It is compelling that
health management organizations in the United States,
where cost and profits are considerations, have started
investing in housing as a strategy to reduce health care
expenditures [13, 18, 30].
In order to achieve study objectives, we used a popula-
tion segmentation method recently developed by the
Canadian Institute for Health Information (CIHI). The
population grouping methodology (‘Pop Grouper’) builds
clinical and demographic profiles for each person in a
population, including health system non-users.
CIHI’s population grouping methodology enables
health system planners and policy-makers to use evi-
dence to support decision-making. This assists CIHI and
its clients monitor population health and diseases, pre-
dict health care utilization patterns and explain varia-
tions in health care resource use, provide a foundation
for funding models, and, facilitate standardization of
populations for inter-provincial analyses [10] (see
Methods and Additional file 1).
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Given rising health care costs, increased demand from
growing elderly populations with multi-morbidity, and,
health consuming more and more of the total gross do-
mestic product in many countries around the world, pol-
icy makers and health researchers have, reasonably, been
looking to the population of ‘high-cost users’ for cost
savings.
Theoretical framework
As this research uses health care utilization data, it is
important to understand the theoretical framework sur-
rounding health care utilization in general. The ‘Behav-
ioural Model of Health Services Use’ developed by RM
Andersen in 1968 (updated in 1995 and renamed the
‘Andersen Health care Utilization Model’) is considered
foundational work in this area [3].
This conceptual model describes the factors that lead
to the use of health services. According to the model,
there are different dynamics that affect an individual’s
health care utilization. Andersen categorizes predictors
into three categories: need, enabling and predisposing
factors [3, 5]. Briefly, predisposing characteristics are
those that predispose individuals to use or not use health
care services (such as age, sex, ethnicity). Enabling char-
acteristics are those that either increase or decrease the
likelihood of health care service use (such as trust of
health care system, income level). Need characteristics
are those related to health care service, both perceived
and actual need, such as the presence of chronic
conditions.
The model makes a distinction between equitable and
non-equitable access to health care services. Equitable
access relates to predisposing factors and need. Inequit-
able access relates to predisposing and enabling factors.
For example, an individual who believes Western med-
ical health care services are beneficial to their perceived
need are more likely to seek care; however, the ability to
access services might vary based on ethnicity, sexual
orientation, economic status, and other factors.
To the best of our knowledge, this is the first study to
segment the population into clinically meaningful sub-
groups, define high-cost use within each sub-group and
include a measure of socio-economic status in multivari-
able regression models.
Methods
Due to the availability of administrative health data
through in-kind support from host institutions and data-
sharing agreements, this study focuses on the provincial
population of Saskatchewan, Canada (population ~ 1.2
million), a Canadian province with a central provincial
health insurer. All Saskatchewan residents receive pro-
vincial health care benefits - with the exception of less
than 1% of the population for whom benefits are
provided by the federal government (members of the
armed forces and federal penitentiary inmates) [8]. Every
provincial resident with a valid health service number
(‘health card’) for at least 1 day from April 1, 2015 to
March 31, 2017 was eligible for study.
Population segmentation method
The Canadian Institute for Health Information (CIHI)
population grouping methodology was used to segment
the study population into clinically meaningful and mu-
tually exclusive health profile groups [10] (Additional file
1). Throughout the world, diagnosis-related grouping
(DRG) methodologies are used to group alike disease
conditions. American DRGs are readily available for use
in Canada; however, these models have two significant
drawbacks: 1) not designed using Canadian data and 2)
they are intellectual property of the company that pro-
duce them, and, as such, are relatively expensive to
purchase.
In brief, CIHI’s population grouping methodology uses
a combination of administrative health databases and
provincial health registry systems to ‘tag’ each resident
with any of the 239 health conditions. These binary tags
(0/1) form the ‘building block’ of the grouping method-
ology and are not mutually exclusive; an individual can
have any number of applicable health conditions. The
presence of health conditions are determined by linking
data from hospitalizations, physician visits, hospital day
surgeries, emergency department visits and long-term
care. The method uses 24 months of data to determine
health conditions (n = 239), branches (n = 164) and
health profile groups (n = 16). Please see ‘Additional file
1’ for details.
Unlike common comorbidity measures such as the
Charlson or Elixhauser indexes (Southern, 2004) the Pop
Grouper does not require an individual to have been
hospitalized; Case Mix Groups (a DRG) similarly require
the individual to have been hospitalized. Pop Grouper
categories are available for every resident, including
non-users of the health care system. Unlike propri-
etary DRGs or other population segmentation
methods, Pop Grouper was developed in Canada,
underwent extensive validation exercises using Canad-
ian data and its development made use of Canadian
clinical content experts [10].
During the course of the study, we identified a further
‘health profile group’, ‘Long-term care (LTC) resident’;
the RAI-LTC 2.0 (see ‘Databases’ for details) was used to
identify long-term care residents. After health profile
grouping, logistic models were constructed for each pro-
file group to understand factors associated with ‘high-
cost health care use’ (defined as > = 90th percentile
within health profile groups). Independent variables in
the models were those commonly available in
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administrative health databases (demographic and health
care utilization data). We used an area-based measure of
health inequity in our modelling. In Canada, a measure
developed by the Institute National Santé Publique du
Quebec divides the population, at the neighbourhood
level, into deprivation quintiles. The five categories seg-
ment the population into the most privileged (quintile 1)
to the most deprived (quintile 5). Total deprivation is a
combination of total household income, education and
employment levels [15].
We made use of Andersen’s behavioural model and
theoretical framework for health services use in describ-
ing predictors of interest [3, 5]. Where the data is in
routine administrative health data, these variables are in
the models.
Databases
Detailed descriptions of Saskatchewan Health databases
are available elsewhere [8]. In brief, demographic charac-
teristics, location of residence, and neighbourhood in-
come quintile were extracted from the Personal Health
Registration System (PHRS) for individuals with > = 1 day
of valid health insurance coverage within the study
period. Hospital data extracted from the CIHI-Discharge
Abstract Database (DAD) includes inpatient and day
surgery records for the province of Saskatchewan. Out-
of-province hospitalizations for Saskatchewan residents
were included; transfers were included but ‘counted’ as
one hospitalization. The International Classification of
Diseases (ICD), 10th revision, Canadian Version (ICD-
10-CA) was used in the DAD to record up to 25 diagno-
ses at discharge, including the primary responsible diag-
nosis for that hospitalization. Data on physician services
are contained in the Medical Services Claims Database.
Physicians paid on a fee-for-service basis submit billing
claims to the provincial health ministry; a single diagno-
sis using a three-digit ICD-9 code is on each claim. The
same single diagnosis is on every claim submitted for a
single visit – multiple service claims by the same phys-
ician, same patient, and same day counted as one ‘visit’.
Salaried physicians can submit billing claims for admin-
istrative purposes (shadow billing); however, claims from
salaried physicians involve under-reporting resulting in
fewer physician claims in the data than in practice [24].
The provincial Resident Assessment Instrument-
Minimum Dataset for long-term care facilities (RAI-
LTC 2.0) defined residents of long-term care facilities.
Home care data is available in the Resident Assessment
Instrument-Minimum Dataset for home care facilities
(RAI-HC). Emergency department (ED) visit data was
recorded in National Ambulatory Care Reporting System
(NACRS); however, for the study period < 50% of the
provincial emergency departments were NACRS-
reporting facilities resulting in under-reporting of ED
visits. Prescription drug data was used to calculate total
government paid prescription drug costs at the
individual-level (see ‘Outcome’), but, drug data was not
extracted as health care utilization.
Death was defined in a ‘derived death file’ (combin-
ation of death data from various administrative health
databases) created by the Saskatchewan Health Quality
Council for research purposes. Nominal variables were
removed (i.e.) name and health services numbers and,
data sets linked at the individual-level using a unique
non-identifiable number generated by eHealth
Saskatchewan.
Outcome
We calculated total health care costs for each individual
for the study period. Health care costs were a sum, at
the individual-level, of total costs associated with hospi-
talizations (both in-patient and day surgery), physician
visits, emergency department visits, long-term care beds
and prescription drugs. We accounted for inflation by
adjusting all health care costs to the year 2015. The
CIHI Resource Intensity Weight (RIW) value at the
patient-level was multiplied by the CIHI derived value
‘cost of a standard hospital stay’ to calculate
hospitalization costs. In the absence of RIWs for LTC in
Saskatchewan, we used a per-diem approach to calculate
LTC costs (per-diem value calculated using LTC actual
expenditure, resident fees and number of LTC beds).
Calculations used total government-paid costs for each
database. We assigned costing variables to their fiscal
year of occurrence. Total health care costs attributed to
each individual in the study population were calculated
using the person-level costing methodology developed
by Wodchis et al. Briefly, this methodology provides
guidance on how to identify unit costs associated with
individual health care utilization of emergency depart-
ments, hospitalizations, physician visits, long-term care
and prescription drugs. The method includes the ability
to combine these costs with utilization data from admin-
istrative health databases; providing a measure of direct
health care costs incurred by government. Each of the
administrative health databases calculates cost in a dif-
ferent way – we then unified the calculation across the
databases by combining them as the ‘total cost per
person’.
In the current study, we defined high-cost status
within each health profile group. Study cohort members
considered ‘high-cost’ vary by health profile group; how-
ever, we consistently defined high-cost as the 90th per-
centile of total cost within the health profile group.
Total insurance coverage length of time was not avail-
able for analysis limiting our ability to account for
death/relocation during the study period (individuals
with less follow-up time would have lower costs, see
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Limitations). For each health profile group (n = 16)
‘high-cost users’ were uniquely identified within the
health profile group as those individuals exceeding the
90th percentile of group-specific total health care costs
(n = 10% within each health profile group). The health
profile groups with the highest total costs (n = six, ex-
cluding palliative care and long-term care residents)
were modelled to assess factors associated with high-
cost use: ‘Major acute’, ‘Major chronic’, ‘Major cancer’,
‘Moderate chronic’, ‘Major Newborn’ and ‘Other Mental
Health’.
Predictors
Health care utilization variables are, in most instances,
directly related to health care costs. Comorbid condi-
tions, age, sex, geographical location and socio-
economic status variables are, in most instances, poten-
tially confounding variables in the relationship between
utilization and cost [29].
Demographic and socio-economic variables (geo-
graphic location, age, sex; predisposing factors; neigh-
bourhood income quintile; predisposing and enabling
factors) were defined as of study index date (April 1,
2015) and extracted from the provincial Personal Health
Registry System. Chronic comorbid conditions were
identified using the health condition ‘tags’ embedded
within the Pop Grouper (need factors). Health care
utilization variables - number of physician visits, number
of emergency department visits, number of hospitaliza-
tions, home care visits, long-term care residency, length
of stay in hospital and alternate level of care hospital
days - were extracted from the relevant administrative
health database, by fiscal year, for the duration of the en-
tire study period (April 1, 2015 to March 31, 2017). ‘Al-
ternate level of care’ hospital days refer to those days
spent in hospital where the level of acuity is not needed
for the patient, however, there does not exist a suitable
place for the patient to be transferred to; most typically,
individuals are awaiting a LTC bed [14].
We defined health profile groups using the CIHI
Population Grouping Methodology software. A detailed
description of this methodology precedes this section.
We used relevant binary health condition ‘tags’ to define
cancer, dialysis, mental health and neonatal intensive
care conditions. Individuals ‘tagged’ with > = one of these
health conditions were considered to have the relevant
condition(s). We defined multiple chronic conditions
using the same binary health conditions tags for minor,
moderate and major chronic health profile groups. Based
on descriptive analyses of the data, any individual with
> = three of these chronic condition ‘tags’ were consid-
ered to have multiple chronic conditions. Categorical
variables of health care utilization (‘high’ number of
visits versus not) were defined as any individual > = 75th
percentile of total study population health care
utilization (this equated to: physician visits> = 23; emer-
gency department visits > = one and hospitalizations > =
one over the study period). The 75th percentile cut-off
was used as descriptive statistics indicated the continu-
ous count variables sharply rose at this value; thus mark-
ing a potential difference between ‘high’ and ‘low’
(subsequently modelled to understand the effect). See
Table 1 for descriptive statistics of all study variables
and Table 2 for Pop Grouper data summary.
Statistical analyses
Following univariate and bivariate analyses, we used
multivariable regression modelling to delineate factors
associated with high-cost use; as defined within each
health profile group. Logistic regression model effect se-
lection was achieved by limiting the number of covari-
ates to those contributing most to outcome measures by
choosing the model with the smallest Akaike’s informa-
tion criterion (AIC) [1]. We explored all interaction
terms analytically; only those deemed biologically plaus-
ible by clinician contributors and previous studies were in-
cluded in the models. Where missing values were present
in the PHRS (income quintile and location of residence), a
categorical value of ‘missing’ was created in order to allow
for sensitivity analyses, with and without the subjects with
missing data. Sensitivity analysis, with and without missing
data, were conducted. All analyses were conducted using
SAS© Enterprise Guide version 7.1 [23].
The study proposal underwent ethical review and ap-
proval by the University of Saskatchewan Biomedical Re-
search Ethics Board and the University of Prince Edward
Island Research Ethics Board for research involving hu-
man subjects.
Results
We identified a total of 1,175,147 individuals, residents
of Saskatchewan, excluding residents of long-term care,
with health insurance coverage of at least 1 day from
April 1, 2015 to March 31, 2017 and person-level costing
data (Fig. 1). Regardless of health condition, LTC resi-
dents were consistently high-cost health care users and
therefore excluded from further study. In descriptive
analyses of the provincial population, high-cost health
care users (n = 117,512) were more likely to be older
(80+ years), female, residents of rural Saskatchewan,
lower income, have more than one chronic condition
and die during the study period compared to non-high
cost users. Compared to non-high cost users, high-cost
users were more likely to have higher health care
utilization, such as, home care services, be hospitalized
(with longer lengths of stay and more ‘alternate level of
care’ hospitalizations), visit the emergency department
and have increased physician visits (Table 1); these
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Table 1 Descriptive epidemiology, demographics and health care utilization variables, by cost category, study population, April 1,
2015 – March 31, 2017 (n = 1,175,147)
Lowest 90%, Saskatchewan
(n = 1,057,635)
Top 10%, Saskatchewan
(n = 117,512)
Age
18–79 years 1,022,482 (96.7%) 100,667 (85.7%)
80+ years 35,153 (3.3%) 16,845 (14.3%)
Sex
Male 542,573 (51.3%) 49,906 (42.5%)
Female 515,062 (48.7%) 67,606 (57.5%)
Geographic location
Urban 711,058 (67.2%) 77,693 (66.1%)
Rural 317,614 (30.0%) 36,656 (31.2%)
Missing 28,963 (2.7%) 3163 (2.7%)
Neighbourhood income
1 (least affluent) 225,650 (21.3%) 26,426 (22.5%)
2 192,838 (18.2%) 21,918 (18.7%)
3 177,797 (16.8%) 19,685 (16.8%)
4 202,522 (19.2%) 22,363 (19.0%)
5 (most affluent) 176,755 (16.7%) 18,710 (15.9%)
Missing 82,073 (7.8%) 8410 (7.2%)
Health profile category
Palliative 1456 (0.1%) 4754 (4.1%)
Major acute 19,010 (1.8%) 15,723 (13.4%)
Major chronic 20,292 (2.0%) 17,511 (14.9%)
Major newborn 1519 (0.1%) 1159 (1.0%)
Major mental health 11,031 (1.0%) 6581 (5.6%)
Major cancer 4803 (0.5%) 3908 (3.3%)
Moderate acute 63,528 (6.0%) 13,492 (11.5%)
Moderate chronic 87,826 (8.3%) 24,950 (21.2%)
Other cancer 4595 (0.4%) 1321 (1.1%)
Other mental health 58,587 (5.5%) 3794 (3.2%)
Obstetrics 22,399 (2.1%) 12,794 (10.9%)
Minor acute 424,832 (40.2%) 7087 (6.0%)
Minor chronic 146,122 (13.8%) 3731 (3.2%)
Healthy newborn 9601 (0.9%) 412 (0.4%)
Health system user, no health conditions 52,527 (5.0%) 83 (0.1%)
Health system non-user 129,507 (12.2%) 212 (0.2%)
Multi-morbidity (> = 3 conditions)
Yes 96,570 (9.1%) 54,392 (46.3%)
No 961,065 (90.9%) 63,120 (53.7%)
Died during study period
Yes 9244 (0.9%) 11,686 (9.9%)
No 1,048,391 (99.1%) 105,826 (90.1%)
Home care client
Yes 47,228 (4.5%) 34,357 (29.2%)
No 1,010,407 (95.5%) 83,155 (70.8%)
Number of hospitalizations
(mean/SD) 0.22 (0.6) 2.1 (2.1)
Length of stay (LOS) in hospital (days)
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findings varied by each health profile group (data not
shown).
In terms of health profile groups, there were differ-
ences between high-cost users within groups compared
to general population high-cost users. The groups ‘minor
acute disease’, ‘health system non-user’, ‘minor chronic
disease’ and ‘moderate chronic disease’ accounted for
the majority of the study population. The groups ‘mod-
erate chronic’, ‘major chronic disease’, ‘major acute dis-
ease’, ‘moderate acute’, and ‘obstetrics’ accounted for the
majority (71.9%) of high-cost users. Overall, high-cost
users in Saskatchewan comprised 10% of the study
population but accounted for 41% of total health care
costs in the study period. The following summarizes data
by health profile group.
Major chronic disease health profile group
Risk factors associated with high-cost use were assessed
for individuals categorized as ‘major chronic disease’
over the study period. Using available variables and tak-
ing known risk factors for high-cost use into account,
low income was significantly associated with high-cost
health care use (OR = 29.4; 95% CI: 19.4–44.7); low income
interacted with length of hospital stay exceeding 3 days in
the study period. Individuals who did not have low income
but did have a length of stay > = 3 days had a lower risk of
high-cost health care use compared to individuals with low
neighbourhood income and a length of hospital stay > = 3
days (OR: 15.3; 95% CI: 12.9–18.1) (Table 3).
Moderate chronic disease health profile group
Under the ‘moderate chronic disease’ health profile group,
those with low neighbourhood income and high numbers
of hospitalizations were more likely to be high-cost users,
compared to low numbers of hospitalizations and not low
income (OR = 4.8; 95% CI: 4.3–5.2) (Table 4).
Major acute disease health profile group
In the major acute disease health profile group, high-
cost use was associated with long hospital stays (OR:
35.5; 95% CI: 26.8–47.1). In addition, among those with
multiple chronic conditions and high numbers of phys-
ician visits had a reduced risk of high-cost health care use
(OR: 2.1 versus OR: 3.8; 95% CI: 2.3–6.2) (Table 5).
Table 1 Descriptive epidemiology, demographics and health care utilization variables, by cost category, study population, April 1,
2015 – March 31, 2017 (n = 1,175,147) (Continued)
Lowest 90%, Saskatchewan
(n = 1,057,635)
Top 10%, Saskatchewan
(n = 117,512)
(mean/SD) 0.72 (7.1) 13.0 (33.1)
Alternate level of care
Yes 2521 (0.2%) 4340 (3.7%)
No 1,055,114 (99.8%) 113,172 (96.3%)
Mental health condition
Yes 108,044 (10.2%) 29,795 (25.4%)
No 949,591 (89.8%) 87,717 (74.7%)
Dialysis
Yes 1657 (0.2%) 3287 (2.8%)
No 1,055,978 (99.8%) 114,225 (97.2%)
Emergency department visits
mean/SD 0.2 (0.6) 0.8 (2.4)
Family physician visits
mean/SD 4.4 (5.6) 12.8 (12.4)
Specialist physician visits
mean/SD 2.7 (6.1) 16.0 (23.2)
Total physician visits > = 23/yr
Yes 206,751 (19.6%) 96,693 (82.3%)
No 850,884 (80.5%) 20,819 (17.7%)
History of hospitalizations > = 1/yr
Yes 41,575 (3.9%) 59,502 (50.6%)
No 1,016,060 (96.1%) 58,010 (49.4%)
Average annual health care cost ($)
(mean/SD) $642 ($895) $16,316 ($23,992)
Total health care cost ($, %) $2,049,772,060 (58.7%) $1442,545,027 (41.3%)
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Major cancer disease health profile group
In the major cancer health profile group, high-cost use
was associated with health care utilization variables
(emergency department, home care hospitalizations and
length of stay) and the presence of multiple chronic con-
ditions (Table 6).
Major newborn health profile group
In the ‘major newborn’ health profile group, newborn ba-
bies in low-income neighbourhoods were at increased risk
of high-cost use – having increased visits to a physician
reduced this risk (OR = 1.44 versus OR = 0.81) (Table 7).
Other mental health profile group
We aimed to model the costliest health profile groups,
in terms of average cost, which would include the ‘major
mental health’ group. However, in Saskatchewan, a sys-
tematic error in electronic medical databases throughout
the province incorrectly defines ICD-9 code 298 as ‘de-
mentia’ as opposed to the correct definition of ‘inorganic
psychoses’. Due to this error, the ‘major mental health’
health profile group has a large preponderance of indi-
viduals > = 80 years with high health care utilization;
likely indicative of dementia patients.
As mental health and addiction is a known driver of
high-cost health care use [29], we include results for the
‘other mental health’ health profile group, not one of the
costliest groups, but, a representation of a mental health
and addictions health profile group.
In the ‘other mental health’ category low income inter-
acted with high physician visits; those with low income
and high physician visits had an increased risk of high-
cost use (OR = 5.2; 95% CI: 4.8–5.5) compared to indi-
viduals not low income with high physician visits (OR =
3.35; 95% CI: 3.02–3.72) (Table 8).
Discussion
Rising health care costs is a significant challenge for health
care systems in Canada and around the world. The
current study aimed to understand high-cost health care
users from the perspective of a provincial health insurer.
Using variables readily available in provincial administra-
tive health databases, in combination with CIHI’s Popula-
tion Grouping methodology, study results add to the
evidence available to decision-makers as they develop pol-
icies to reduce costs, and, ultimately, improve the health
of this population.
In the majority of health profile groups modelled, a
measure of socio-economic status – neighbourhood in-
come quintile – was statistically significantly associated
with high-cost use.
Measures of socio-economic status (SES), such as, un-
stable housing, and food insecurity, have previously been
found to be associated with high-cost health care use, [4,
22, 28, 30], To the best of our knowledge this is the first
population-based study to define high-cost users within
their health profile group and consider SES in regression
models. We hypothesize this method provides better
specificity to understanding high-cost users of health
care services.
Equity in health is of utmost importance. We feel that
by providing quantitative evidence demonstrating the as-
sociation between low socio-economic status and high-
cost health care use within specific health profile groups
Table 2 Mean health care costs, by health profile category and high-cost use, Saskatchewan, excluding long-term care residents,
April 1, 2015 to March 31, 2017 (n = 1,175,147)
Health profile categorya n Cost per person (mean, SD)
Palliative 6210 $30,301 (39,692)
Major Newborn 2678 $14,714 (39,401)
Major Acute 34,733 $12,062 (26,737)
Major Chronic 37,803 $11,663 (23,434)
Major Cancer 8711 $9652 (15,886)
Major Mental Health 17,612 $8389 (17,655)
Moderate Chronic 112,776 $3788 (7064)
Other Cancer 5916 $3782 (6320)
Obstetrics 35,193 $3489 (4273)
Moderate Acute 77,020 $2843 (4820)
Healthy Newborn 10,013 $2023 (1669)
Other Mental Health 62,381 $1442 (3306)
Minor Chronic 149,853 $918 (2188)
Minor Acute 431,919 $518 (1731)
Health System User, no health conditions 52,610 $160 (1221)
Health System non-user 129,719 - (−)
aMutually exclusive health profile categories assigned by highest resource intensity April 1, 2015 to March 31, 2017
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– policy makers can create interventions aimed to both
reduce costs and improve health.
A recent study out of the US similarly found that
population segmentation methods were useful for defin-
ing actionable high-cost user cohorts [11]. The authors
defined six cohorts: under 65 years of age and disabled/
end-stage renal disease; frail elderly; major complex
chronic, minor complex chronic; simple chronic; and
relatively healthy. Individuals in the top 10% of spending
were high-cost. The authors conclude that using simple
criteria that segments, in this case, Medicare beneficiar-
ies, into meaningful subgroups is a useful method to tar-
get interventions –a conclusion similar to the current
study [11]. Besides only using data specific to one popu-
lation (Medicare recipients), and, a non-validated ap-
proach to segmentation, this study is further limited by
the fact that “high-cost use” was defined overall and not
within each population segment. In addition, the authors
Fig. 1 Study cohort inclusion/exclusion criteria
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did not conduct analyses beyond descriptive statistics,
limiting the ability of their work to point to risk factors
associated with high-cost use within the population
segments.
Another recent study from the US also described the util-
ity of population segmentation in describing high-cost users.
This study employed density based cluster analysis to deter-
mine the population segments; however, their analysis did
not include any indicators of socio-economic status [16]. A
recent systematic review of high-cost health care use, syn-
thesizing 55 studies around the world, indicated that high-
cost use was associated with multiple chronic conditions,
older age, mental illness, end-of-life care, higher income
(United States) and lower income (all other countries). Most
relevant to the current work, however, the authors note that
given the heterogeneity of high-cost user populations seg-
mentation methods to define specific groups prior to ana-
lyses is recommended [29].
Although our study population is limited to one pro-
vincial jurisdiction in Canada, the methods used is
generalizable and useful for other jurisdictions where a
central health insurer is interested in defining their high-
cost health care population. High-cost users are not a
homogenous group. Segmenting the population into
health profile groups shows promise in describing the
populations that consume the most health care
resources.
Policy and decision-makers require actionable infor-
mation. Providing descriptive epidemiology on high-cost
health care users is not enough – researchers must pro-
vide actionable information for policy and decision-
makers. The methods and analyses conducted to arrive
at a reasonable conclusion about what is driving high-
cost health care use are often complex. It is incumbent
upon implementation scientists to know how to commu-
nicate complex findings in a simple, easy to understand
manner, in addition to focusing on what is amenable to
change, such as socio-economic status, either at the indi-
vidual or population-level.
Limitations
This study has several limitations, many inherent to epi-
demiological studies reliant on administrative health da-
tabases. Additional variables, such as food insecurity [27]
have been found to be associated with high-cost use and
may have been useful in modelling; however this data
was not available for analysis. Community-based ser-
vices, either publicly funded or private fee-for-service,
(individual/group counselling, treatment centres, private
nursing services, others) may be associated with high-
cost use but not available for analysis. This is one of the
largest drawbacks of studies making use of administra-
tive health data – important confounders and predictors
are often not available for analysis. Recent model simula-
tion work has identified ways to impute some of these
missing variables, though little is known if these
methods work in practice [25].
Readers will note that the epidemiological context of
this study is somewhat ‘muddy’ – the outcome of ‘high-
cost use’ within specific health profile groups can be re-
lated to the definition of the group itself (a combination
of resource intensity and severity). We acknowledge this
less than ideal context, however, we feel the population
segmentation method still provides utility.
While we did account for the costs of prescription
drugs, we did not examine the types of prescription
drugs taken. There may well be an association between
drug class and high-cost health care use.
Our study focused on cost; however, we could not
measure all all health care system costs, such as cancer
treatment/diagnosis, laboratory testing, home care, pub-
lic health, travel costs (air transfers and ground ambu-
lance) and all health care administrative costs. High-cost
Table 3 Logistic regression models comparing high-cost health
care users and not high-cost use, excluding long-term care
residents, by health profile category, Saskatchewan, April 1, 2015
to March 31, 2017 (n = 1,175,147). High-cost use within major
chronic health profile group, odds ratios (Total n = 37,803; High-
cost users n = 3781)
Focus setting Comparison setting OR 95% CI
Home care (=yes) Home care (=no) 1.96 1.82–2.12
LOS = y; low income = y LOS = n; low income = y 29.42 19.37–44.69
LOS = y; low income = n LOS = n; low income = n 15.25 12.86–18.09
Multi chronic dx = y;
High Dr. visits = y
Multi chronic dx = y;
High Dr. visits = n
4.99 3.46–7.23
Multi chronic dx = n;
High Dr. visits = y
Multi chronic dx = n;
High Dr. visits = n
2.25 1.54–3.29
Table 4 Logistic regression models comparing high-cost health care users and not high-cost use, excluding long-term care
residents, by health profile category, Saskatchewan, April 1, 2015 to March 31, 2017 (n = 1,175,147). High-cost users within moderate
chronic health profile group, odds ratios (Total n = 112,776; High-cost users n = 11,277)
Focus setting Comparison setting OR 95% CI
Home care (=yes) Home care (=no) 2.04 1.94–2.14
Mental health (=yes) Mental health (=no) 1.35 1.28–1.43
Hx of hosp = y; low income = y Hx of hosp = n; low income = y 4.76 4.32–5.23
Hx of hosp = y; low income = n Hx of hosp = n; low income = n 4.06 3.88–4.25
Anderson et al. International Journal for Equity in Health          (2019) 18:171 Page 10 of 14
users comprised a small proportion (10%) of the study
population, yet accounted for 41% of measured health
care costs. Given our inability to account for health care
costs in previous studies, such as cancer diagnosis/treat-
ment and laboratory costs, our findings are in general
agreement with the literature.
In defining comorbidities, we relied on available health
condition ‘tags’ in the Pop Grouper software; however,
this method has not been validated against a gold stand-
ard method of chronic disease indicators (such as the
Canadian Chronic Disease Surveillance System) [9]. This
study relied heavily on population segmentation, which
may not always accurately classify individuals. For ex-
ample, a person may be a high-cost user due to an opi-
oid addiction, but, be classified into heart disease if the
condition comprised their costliest health care
utilization. Alternatively, individuals who did have a spe-
cific health condition under study, but, did not ever seek
medical treatment for it, would be classified as ‘health
system non-users’. The segmentation methods may inad-
vertently not delineate specific groups associated with
high-cost use, such as medical error [16].
We were unable to account for the specific days of
insurance coverage for individuals who died/moved
out of province; however, reassuringly 93% of study
cohort members had complete follow-up time. As our
study population comprised individuals followed over
24 months we did not consider high-cost health care
use that persisted over time – differences in results
would likely occur between episodic and persistent
high-cost use.
We were limited by underreporting of emergency de-
partment visits in Saskatchewan as, during the study
period, only < 50% of the provincial emergency depart-
ments were NACRS-reporting facilities. Similarly, phys-
ician claims data would be limited in missing
alternative-payment physician claims that do not shadow
bill. Many psychiatrists in Saskatchewan are on
alternative-payment schedules; this may disproportion-
ately underestimate the number of individuals in mental
health groups.
It should be noted that all of the models, while
demonstrating reasonable calibration and validation,
had low pseudo R2 values. This indicates the variables
available for analysis are not explaining the majority
of the variation between high-cost use and not high-
cost use. The use of additional information not com-
monly available in administrative health databases,
such as, social support, trust in the health care sys-
tem, individual-level indicators of socio-economic sta-
tus and others would likely greatly improve model
variation explanation.
Costing data was missing for 54,948 individuals in the
study population. It is possible that inclusion of those in-
dividuals would change model interpretation; however,
given the small numbers of missing values (4%) we feel
the impact of this limitation is likely to be minimal.
Additionally, high-cost health care use, while concern-
ing from an insurer perspective, is not necessarily an ad-
verse outcome. For example, high-cost health care use in
obstetric patients may be entirely appropriate; driven by
increased visits to specialists during a high-risk preg-
nancy and associated with better health outcomes. We
were unable to assess quality of life outcomes in this
study.
Lastly, ‘high-cost’ use definitions vary between those
who exceed the 90th percentile, 95th percentile or 99th
percentile of total population costs. We chose to focus
on individuals in the top 10% of total costs per fiscal
year as the majority of high-cost user studies in the lit-
erature (see Introduction) define ‘high-cost use’ as those
in the top 10% of costs. However, we acknowledge the
arbitrary nature of any cut-off value used.
Table 5 Logistic regression models comparing high-cost health care users and not high-cost use, excluding long-term care
residents, by health profile category, Saskatchewan, April 1, 2015 to March 31, 2017 (n = 1,175,147). High-cost users within major
acute disease health profile group (Total n = 34,733; High cost users n = 3473)
Focus setting Comparison setting OR 95% CI
Length of hospital stay > = 3 days Length of hospital stay < 3 days 35.5 26.8–47.1
Multi chronic dx = y;
High Dr. visits = y
Multi chronic dx = n;
High Dr. visits = y
2.1 1.9–2.3
Multi chronic dx = y;
High Dr. visits = n
Multi chronic dx = n;
High Dr. visits = n
3.8 2.3–6.2
Table 6 Logistic regression models comparing high-cost health
care users and not high-cost use, excluding long-term care
residents, by health profile category, Saskatchewan, April 1, 2015
to March 31, 2017 (n = 1,175,147). High-cost users within major
cancer health profile group (Total n = 8711; High-cost users n =
872)
Predictor Odds ratio 95% CI
Length of hospital stay > = 3 days (=yes) 23.11 13.82–38.65
High emergency department visits (=yes) 1.59 1.36–1.85
History of hospitalization (=yes) 1.61 1.26–2.05
Home care (=yes) 2.36 2.01–2.78
Multiple (> = 3) chronic conditions (=yes) 1.68 1.44–1.97
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Future work
Our finding that ‘palliative’ is one of the costliest health
profile groups is not unexpected [2, 19] and warrants
further research to understand factors associated with
this increased cost.
In only two health profile groups, ‘major acute’ and
‘major cancer’, high-cost use was not associated with
lower socio-economic status. The factors associated with
high-cost use in these two groups (major acute and major
cancer) are health care utilization variables (such as
lengthy hospital stays) which would be expected. The
number of days in hospital avoided with good continuity
of health care providers in the community would be inter-
esting to quantify for major acute and major cancer pa-
tients (less expensive use of resources compared to acute
in-patient beds).
Future work could also consider high-cost use over
time, potentially focusing on groups of trajectories, quali-
tative inquiries with high-cost users, linking health care
costing data with other human services costing data to ob-
tain a complete picture of ‘high-cost use’, and spatial ana-
lyses of high-cost use. The two costliest health profile
groups in our study were palliative care and long-term
care residents; the majority of which considered ‘high-cost
users’. A detailed study into end-of-life costs and the rea-
sons behind high-cost use for palliative patients (including
specific interventions that not only save costs, but improve
quality of life for patients); especially given previous
contradictory findings regarding end-of-life costs [2].
Conclusion
Given the heterogeneity, complexity and the natural ‘re-
gression to the mean’ in health care spending, policy and
decision-makers have difficulty devising interventions
aimed at reducing high-cost health care use at a
population level. By segmenting a provincial popula-
tion into clinically meaningful sub-populations and
demonstrating a link between socio-economic status
and high-cost health care use in the majority of
health profile groups, but not all, we feel this study
adds to the body of evidence aimed at understanding
the complexity of high-cost health care use.
Furthermore, this study provides quantitative evi-
dence to support an agenda to improve equity in
health. Within the majority of health profile groups,
and taking into account a myriad of potentially con-
founding variables, individuals with lower socio-
economic status were more likely to be high-cost
health care users. Perhaps, both improved population
health and cost savings could be achieved if policy
makers addressed the underlying inequity.
By grouping the study population into health pro-
files, and understanding factors associated with high
cost use within each specific health profile, the evi-
dence generated becomes more specific, and, poten-
tially actionable. It is impossible to intervene at a
system level on an individual’s age, but system level
interventions can be actioned and directed at improv-
ing socio-economic status, managing multiple comor-
bid conditions and improving end-of-life care.
There are relatively few examples of interventions that
have successfully both reduced costs and improved
health outcomes with respect to high-cost users. Inter-
Mountain Health Care in Utah and the Camden Primary
Care consortium in New Jersey have achieved improved
health outcomes and cost savings by focussing on the
Table 7 Logistic regression models comparing high-cost health care users and not high-cost use, excluding long-term care
residents, by health profile category, Saskatchewan, April 1, 2015 to March 31, 2017 (n = 1,175,147). High-cost use within major
newborn health profile group, odds ratio (Total n = 2678; High cost users n = 267)
Focus setting Comparison setting OR 95% CI
History of hospitalization (=yes) History of hospitalization (=no) 1.52 1.13–2.0
Low income = y;
High Dr. visits = y
Low income = n;
High Dr. visits = y
0.81 0.53–1.25
Low income = y;
High Dr. visits = n
Low income = n;
High Dr. visits = n
1.44 1.00–2.15
Table 8 Logistic regression models comparing high-cost health care users and not high-cost use, excluding long-term care
residents, by health profile category, Saskatchewan, April 1, 2015 to March 31, 2017 (n = 1,175,147). High-cost users within other
mental health profile group (Total n = 62,381; High-cost users n = 6241)
Focus setting Comparison setting OR 95% CI
Home care = y; Hx of hosp = y Home care = y; Hx of hosp = n 5.72 4.81–5.53
Home care = n; Hx of hosp = y Home care = n; Hx of hosp = n 11.66 10.52–12.93
Low income = n;
High Dr. visits = y
Low income = n;
High Dr. visits = n
3.35 3.02–3.72
Low income = y;
High Dr. visits = y
Low income = y;
High Dr. visits = n
5.16 4.81–5.53
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few consuming the most resources. In both instances,
high-cost individuals were a homogeneous group; in
New Jersey the high-cost, high-utilization population
was concentrated in a small geographical area and were
of lower socio-economic status [6]. In Utah, the Con-
nected Care Clinic was designed to serve the ‘complex
few’ – those with multiple chronic conditions and mul-
tiple psycho-social issues (such as unstable housing and
food insecurity). By ‘wrapping services around’ these
complex few InterMountain was able to achieve positive
results [18, 30].
Understanding the demographics, clusters, health care
utilization patterns and predictors associated with high-
cost health care use will be important for identifying op-
portunities for upstream prevention. Providing more tar-
geted, appropriate care and supports for specific sub-
populations, such as, mental health, newborns or multi-
morbid individuals, or, by acting on the determinants of
health to prevent certain types of high-cost use in the
first place could achieve positive results. For example,
we found that for babies born in low-income neighbour-
hoods, increased physician visits decreased the risk of
high-cost use. Related policies could include identifying
at risk pregnant mothers and connecting them to pri-
mary care providers prior to the birth of their baby.
Similarly, home care services could be a priority for
mental health patients coming out of hospital. Given
high-cost use for most groups was associated with low
socio-economic status, we could provide disadvantaged/
vulnerable persons with major chronic disease with one-
on-one social worker support – decreasing health care
costs and improving quality of life. We feel that by de-
veloping well calibrated and discriminatory models
aimed at understanding factors associated with high-cost
use we are providing a piece of the puzzle for policy
makers keen to implement interventions. If successful,
these interventions could both lower costs, but more im-
portantly, improve the health of the population.
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